A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder.

Trial Profile

A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Sep 2011

At a glance

  • Drugs Vilazodone (Primary)
  • Indications Major depressive disorder
  • Focus Adverse reactions; Pharmacogenomic; Registrational
  • Sponsors PGxHealth
  • Most Recent Events

    • 23 Nov 2010 Results presented at the U.S. Psychiatric & Mental Health Congress.
    • 26 May 2010 Positive results data from this trial will be presented at the annual meeting of the American Psychiatric Association (APA 2010), according to a Clinical Data Inc media release.
    • 09 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top